Home » Newsletters » BioWorld

BioWorld

June 27, 2003

View Archived Issues

Unnatural, Outlandish Antibody Sets Stage For Long-Sought Vaccine To Outsmart Deadly HIV

Axonyx Starting Phase III Study Of Phenserine For Alzheimer's

Advisory Panel Recommends Against Serono's Serostim

Other News To Note

Nektar Prices $100M In Notes As It Moves Programs Forward

Drug delivery firm Nektar Therapeutics priced its offering of $100 million in notes reported earlier this week. Read More

MethylGene, Merck Enter Deal On Drugs For Antibiotic Resistance